Found 6 resultsAuthor [ Title] Type Year
Filters: Author is McCarthy, P [Clear All Filters]
Maximizing Accrual to Transplant Trials in Multiple Myeloma (MM): Lessons from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Eastern Cooperative Oncology Group (ECOG) and Cancer and Leukemia Group B (CALGB) Collaboration (Poster). In NCI ASCO Cancer Trials Accrual Symposium. presented at the 2010, Bethesda, MD.. (2010).
Phase II Trial of Parathyroid Hormone After Double Umbilical Cord Blood Transplantation. Biol Blood Marrow Transplant, 18, 1851-1858. presented at the 12/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22766223. (2012).
Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT. Blood, 124, 1372-1377. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982504. (2014).
Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Umbilical Cord Blood Transplantation in Adults: Results of the Prospective Cord Blood Transplantation (COBLT). Biol Blood Marrow Transplant, 11, 2149-2160. presented at the 02/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15682076. (2005).